Grigoriadis Dimitri E. 4/A
4/A · NEUROCRINE BIOSCIENCES INC · Filed Mar 29, 2021
Insider Transaction Report
Form 4/AAmended
Grigoriadis Dimitri E.
Vice President, Research
Transactions
- Award
Stock Option
2021-02-08+42,042→ 42,042 totalExercise: $117.63Exp: 2031-02-08→ Common Stock (42,042 underlying)
Footnotes (1)
- [F1]Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 8, 2021 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.